Tipranavir (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tipranavir" in Serbian language version.

refsWebsite
Global rank Serbian rank
2nd place
4th place
4th place
8th place
18th place
28th place

doi.org (Global: 2nd place; Serbian: 4th place)

  • Doyon L, Tremblay S, Bourgon L, Wardrop E, Cordingley MG: Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir. Antiviral Res. Doyon, L.; Tremblay, S.; Bourgon, L.; Wardrop, E.; Cordingley, M. G. (октобар 2005). „Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir”. Antiviral Research. 68 (1): 27—35. PMID 16122817. doi:10.1016/j.antiviral.2005.07.003. 
  • Tipranavir: PNU 140690, tipranivir. Drugs R D. 2006;„Tipranavir: PNU 140690, tipranivir”. Drugs in R&D. 7 (1): 55—62. 2006. PMID 16620137. doi:10.2165/00126839-200607010-00005. 
  • Temesgen Z, Feinberg J: Tipranavir: a new option for the treatment of drug-resistant HIV infection. Clin Infect Dis. Temesgen, Z.; Feinberg, J. (септембар 2007). „Tipranavir: A new option for the treatment of drug-resistant HIV infection”. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45 (6): 761—9. PMID 17712762. doi:10.1086/520847. . Epub 2007 Aug 7.
  • Luna B, Townsend MU: Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance. Clin Ther. Luna, B.; Townsend, M. U. (новембар 2007). „Tipranavir: The first nonpeptidic protease inhibitor for the treatment of protease resistance”. Clinical Therapeutics. 29 (11): 2309—18. PMID 18158073. doi:10.1016/j.clinthera.2007.11.007. 
  • Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  • Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958. 
  • Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o. 
  • Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t. 
  • Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e. 

harvard.edu (Global: 18th place; Serbian: 28th place)

adsabs.harvard.edu

  • Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o. 

nih.gov (Global: 4th place; Serbian: 8th place)

ncbi.nlm.nih.gov

  • Doyon L, Tremblay S, Bourgon L, Wardrop E, Cordingley MG: Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir. Antiviral Res. Doyon, L.; Tremblay, S.; Bourgon, L.; Wardrop, E.; Cordingley, M. G. (октобар 2005). „Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir”. Antiviral Research. 68 (1): 27—35. PMID 16122817. doi:10.1016/j.antiviral.2005.07.003. 
  • Tipranavir: PNU 140690, tipranivir. Drugs R D. 2006;„Tipranavir: PNU 140690, tipranivir”. Drugs in R&D. 7 (1): 55—62. 2006. PMID 16620137. doi:10.2165/00126839-200607010-00005. 
  • Temesgen Z, Feinberg J: Tipranavir: a new option for the treatment of drug-resistant HIV infection. Clin Infect Dis. Temesgen, Z.; Feinberg, J. (септембар 2007). „Tipranavir: A new option for the treatment of drug-resistant HIV infection”. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45 (6): 761—9. PMID 17712762. doi:10.1086/520847. . Epub 2007 Aug 7.
  • Luna B, Townsend MU: Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance. Clin Ther. Luna, B.; Townsend, M. U. (новембар 2007). „Tipranavir: The first nonpeptidic protease inhibitor for the treatment of protease resistance”. Clinical Therapeutics. 29 (11): 2309—18. PMID 18158073. doi:10.1016/j.clinthera.2007.11.007. 
  • Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  • Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958. 
  • Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t. 
  • Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.